| A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma HY Yoo, MK Sung, SH Lee, S Kim, H Lee, S Park, SC Kim, B Lee, K Rho, ... Nature genetics 46 (4), 371-375, 2014 | 389 | 2014 |
| Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type S Lee, HY Park, SY Kang, SJ Kim, J Hwang, S Lee, SH Kwak, KS Park, ... Oncotarget 6 (19), 17764, 2015 | 158 | 2015 |
| Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma HY Yoo, P Kim, WS Kim, SH Lee, S Kim, SY Kang, HY Jang, JE Lee, ... Haematologica 101 (6), 757, 2016 | 88 | 2016 |
| The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP H Jung, HY Yoo, SH Lee, S Shin, SC Kim, S Lee, JG Joung, JY Nam, ... Oncotarget 8 (10), 17038, 2017 | 61 | 2017 |
| A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients SH Lee, JS Kim, J Kim, SJ Kim, WS Kim, S Lee, YH Ko, HY Yoo Haematologica 100 (12), e505, 2015 | 52 | 2015 |
| TopBP1 and Claspin contribute to the radioresistance of lung cancer brain metastases SH Choi, H Yang, SH Lee, JH Ki, DH Nam, HY Yoo Molecular cancer 13, 1-8, 2014 | 52 | 2014 |
| A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas SJ Kim, DY Shin, JS Kim, DH Yoon, WS Lee, H Lee, YR Do, HJ Kang, ... Annals of oncology 27 (4), 712-718, 2016 | 49 | 2016 |
| Serum survivin and vascular endothelial growth factor in extranodal NK/T-cell lymphoma, nasal type: implications for a potential new prognostic indicator SJ Kim, M Hong, IG Do, SH Lee, KJ Ryu, HY Yoo, JY Hong, YH Ko, ... Haematologica 100 (3), e106, 2015 | 14 | 2015 |
| The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma JH Kang, SH Lee, J Lee, M Choi, J Cho, SJ Kim, WS Kim, YH Ko, HY Yoo BMC cancer 21, 1-11, 2021 | 12 | 2021 |
| A novel GPR119 agonist DA-1241 preserves pancreatic function via the suppression of ER stress and increased PDX1 expression MK Kim, YH Cheong, SH Lee, TH Kim, IH Jung, Y Chae, JH Lee, EK Yang, ... Biomedicine & Pharmacotherapy 144, 112324, 2021 | 8 | 2021 |
| Effects of DA-1241, a novel GPR-119 agonist, on lipid control in disease models mediated by regulating an AMPK/SREBP1c signaling path MK Kim, TH Kim, S Lee, IH Jung, YN Chae, JS Yang Diabetes 66, LB43-LB43, 2017 | 2 | 2017 |
| GPR119 activation by DA-1241 alleviates hepatic and systemic inflammation in MASH mice through inhibition of NFκB signaling SH Lee, H Park, EK Yang, BR Lee, IH Jung, TH Kim, MJ Goo, Y Chae, ... Biomedicine & Pharmacotherapy 166, 115345, 2023 | | 2023 |
| COMBINATION TREATMENT OF A GPR119 AGONIST DA-1241 WITH A DPP4 INHIBITOR SYNERGISTICALLY IMPROVES SYSTEMIC AND HEPATIC INFLAMMATION IN NASH MICE. H Park, SH Lee, MK Kim The Liver Meeting Digital Experience™, 2020 | | 2020 |
| 216-LB: A Novel GPR119 Agonist, DA-1241, Reduces Hepatic Inflammation and Fibrosis in Preestablished Diet-Induced NASH Mice H Park, SH Lee, MK Kim Diabetes 69 (Supplement_1), 2020 | | 2020 |
